Understanding HIV resistance, fitness, replication capacity and compensation: targeting viral fitness as a therapeutic strategy

Author： Buckheit Jr Robert W  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.8, 2004-08, pp. : 933-958

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Viral Infectivity Factor: A Novel Therapeutic Strategy to Block HIV-1 Replication

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 7, 2013-06 ,pp. : 1047-1055

Bentham Science Publishers

Access to resources Recommend Favorite

Insertions and Deletions in HIV-1 Reverse Transcriptase: Consequences for Drug Resistance and Viral Fitness

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-01 ,pp. : 1811-1825

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Resistance, Virus Fitness and HIV-1 Mutagenesis

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4065-4070

Bentham Science Publishers

Access to resources Recommend Favorite

Viral tropism, fitness and pathogenicity of HIV-1 subtype C

By Jakobsen Martin R   Ellett Anne   Churchill Melissa J   Gorry Paul R  

Future Virology, Vol. 5, Iss. 2, 2010-03 ,pp. : 219-231

Future Medicine

Access to resources Recommend Favorite

Targeting the Human DEAD-Box Polypeptide 3 (DDX3) RNA Helicase as a Novel Strategy to Inhibit Viral Replication

By  

Current Medicinal Chemistry, Vol. 18, Iss. 20, 2011-07 ,pp. : 3015-3027

Bentham Science Publishers

Access to resources Recommend Favorite